http://www.fpnotebook.com/
AminoglycosideAka: Gentamicin, Garamycin
- Pharmacokinetics
- Maintain Trough <2 ug/ml
- Drawn immediately before next dose
- Maintain Peak at 5-8 ug/ml (4-6 ug/ml for child)
- Draw 1 hour after Intramuscular dose
- Indications for pharmacokinetics followed by PharmD
- Aminoglycoside use over 3 days
- Renal dysfunction
- Precautions
- Administer IV dose over 1 hour
- Adjust dosing per kinetics if >1-2 days use
- Dosing: Infants
- Term Infant
- Gentamycin 2.5 mg/kg/dose IV or IM q8 hours
- Preterm Infant
- Gestational Age >34 weeks and Weight over 2000 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
- Gestational Age <34 weeks
- Weight over 1250 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q18 hours
- Weight Under 1250 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
- Age >7 days
- Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
- Renal Impairment Adjustments
- Serum Creatinine 0.7 to 1.1
- Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
- Serum Creatinine 1.1 to 1.3
- Gentamycin 2.5 mg/kg/dose IV or IM q36 hours
- Serum Creatinine > 1.3
- Gentamycin 2.5 mg/kg/dose IV or IM q48 hours
- Dosing: Children and adults
- Child
- Gentamicin 2 to 2.5 mg/kg IV or IM q8 hours
- Gentamicin 4.5 mg/kg IV q24 hours
- Adults
- Gentamicin 1-1.5 mg/kg IV or IM q8 hours or
- Gentamicin 5-7 mg/kg IV q24 hours
- Risk Factors for Nephrotoxicity
- Advanced age
- Prior renal insufficiency
- Dehydration
- Hypokalemia
- Hypomagnesemia
- Liver disease
- Sepsis
- Drug interactions with other nephrotoxic medications
- Cephalothin (Keflin) and other Cephalosporins
- Cyclosporin A
- Cisplatin
- NSAIDS
- ACE Inhibitors
- Methoxyflurane
- Loop Diuretics
- Amino acids
Navigation Tree